Highlights
The drive is unlikely to start from May 1 due to limited stocks with states
Sudhir Chaudhary explained why uncertainty over getting vaccine still remains
New Delhi: People all over the country were desperately waiting for one thing today and that is OTP or One Time Password. The reason is that the vaccine registration for phase 3 that makes all above 18 years eligible started today at 4 pm.
But the path to a vaccine is not so simple and despite successful registration on apps and web portals, the uncertainty remains.
Zee News Editor-in-Chief Sudhir Chaudhary on Wednesday (April 28) discussed how the opening day of vaccine registration panned out and why the uncertainty over getting vaccine still remains.
Highlights
Courts across the country are hearing cases related to the COVID situation
Sudhir Chaudhary discussed how courts are leading the fight against the pandemic
New Delhi: India is currently struggling with the COVID pandemic. Usually, a health calamity such as this is confined to the hospital. However, in the present situation, the crisis has come out of the hospitals and the COVID battle is being fought in courts across the country.
Zee News Editor-in-Chief Sudhir Chaudhary on Tuesday (April 27) discussed how the courts are leading the fight against the deadly pandemic.
At present various courts, including several high courts and the Supreme Court, are hearing cases related to the COVID situation in the country. They are passing orders and making observations regarding various issues the second wave of the pandemic has raised such as shortage of oxygen, essential medicines and hospital beds.
Highlights
Some people have indulged in hoarding and black marketing of the drug
Sudhir Chaudhary discussed whether the drug is really worth it
New Delhi: As India faces a COVID emergency, there are some people who are seeking to make profit out of the misery of the common people.
Remdesivir, a drug that is said to be effective in the treatment of coronavirus, remains out of reach of the people who need it as some black marketeers in the country are hoarding its stocks. This has led to a shortage of the drug.
Zee News Editor-in-Chief Sudhir Chaudhary on Monday (April 26) discussed how and why the COVID drug Remdesivir has become hard to come by and whether the drug is as good as it is being touted.
Highlights
PM Modi held a high-level meeting with CM of 10 states
Sudhir Chaudhary discussed the drug and Modi s important points
New Delhi: India recorded the world s highest single-day spike with 3,32,730 fresh infections of COVID-19 on Friday. Reports of shortage of oxygen supply have been pouring in from several hospitals across the country.
Even as the country’s vaccination drive continues on full steam, lately it seemed like it was not going to be enough to get hold of the second wave of the COVID pandemic.
At a time like this, the arrival of a new drug could possibly be a game-changer.
DNA Exclusive: No shortage of oxygen in country, why are then patients gasping for air? india.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from india.com Daily Mail and Mail on Sunday newspapers.